parthenolide has been researched along with Hyperplasia in 2 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 2 (100.00) | 29.6817 |
| 2010's | 0 (0.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Brzana, W; Jabłoński, M; Majdan, M; Mitura, A; Parada-Turska, J; Rzeski, W | 1 |
| Anthonavage, M; Garay, M; Liebel, F; Lyte, P; Martin, K; Oddos, T; Shapiro, S; Southall, M; Sur, R; Tierney, N | 1 |
2 other study(ies) available for parthenolide and Hyperplasia
| Article | Year |
|---|---|
Parthenolide inhibits proliferation of fibroblast-like synoviocytes in vitro.
Topics: Animals; Arthritis, Rheumatoid; Bromodeoxyuridine; Cell Line; Cell Proliferation; Fibroblasts; Humans; Hyperplasia; Phytotherapy; Rabbits; Sesquiterpenes; Synovial Membrane; Tanacetum parthenium; Tetrazolium Salts; Thiazoles | 2008 |
Parthenolide-depleted Feverfew (Tanacetum parthenium) protects skin from UV irradiation and external aggression.
Topics: Administration, Topical; Animals; Case-Control Studies; Cells, Cultured; DNA Repair; Environmental Exposure; Erythema; Female; Free Radical Scavengers; Humans; Hydrogen Peroxide; Hyperplasia; Inflammation; Male; Mice; Mice, Hairless; Plant Extracts; Reactive Oxygen Species; Sesquiterpenes; Skin; Skin Aging; Smoking; Swine; Tanacetum parthenium; Ultraviolet Rays | 2008 |